Short communication · 31 Mar 2017
Conference abstractPublished 15 Mar 2017
Endothelial progenitor cells and apoptotic endothelial cell-derived microparticles as biomarker of heart failure phenotypes
Zaporozhye State Medical University, Ukraine
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Chronic heart failure (HF) remains a leading cause of cardiovascular (CV) mortality and morbidity worldwide. Aim: The aim of the study was to investigate whether the pattern of angiogenic endothelial progenitor cells (EPCs) and apoptotic endothelial cell-derived microparticles (EMPs) would be able to differentiate HF with reduced (HFrEF) and preserved (HFpEF) ejection fraction. Methods: 164 chronic HF subjects met inclusion criteria. Patients with global left ventricular ejection fraction âÂ?¥50% were categorized as the HFpEF group (n=79) and those with âÂ?¤45% as the HFrEF group (n=85). Therefore, to compare the circulating levels of biological markers, 35 control subjects without HF were included in the study. All control individuals were age- and sex-matched chronic HF patients. The serum level of biomarkers was measured at baseline. The flow cytometric technique was used for predictably distinguishing circulating cell subsets depending on expression of CD45, CD34, CD14, Tie-2, and CD309 antigens and determining endothelial cell-derived micro particles. CD31+/annexin V+ was defined as apoptotic endothelial cell-derived MPs, MPs labeled for CD105+ or CD62E+ were determined as MPs produced due to activation of endothelial cells. Results: In multivariate logistic regression model T2DM (R2=0.26; P=0.001), obesity (R2=0.22; P=0.001), previous MI (R2=0.17; P=0.012), galectin-3 (R2=0.67; P=0.012), CD31+/annexin V+ EMPs (R2=0.11; P=0.001), NT-proBNP (R2=0.11; P=0.046), CD14+CD309+ cells (R2=0.058; P=0.001), and CD14+СD309+ Tie-2+ cells (R2=0.044; P=0.028) were found as independent predictors of HFpEF. Using multivariate Cox-regression analysis adjusted etiology (previous myocardial infarction), cardiovascular risk factors (obesity, type 2 diabetes mellitus), we found that NT-proBNP (OR 1.08; 95% CI=1.03âÂ?Â?1.12; P=0.001) and CD31+/annexin V+EMPs to CD14+CD309+ cells ratio (OR 1.06; 95% CI=1.02âÂ?Â?1.11; P=0.02) were independent predictors for HFpEF. Conclusion: We found that CD31+/annexin V+EMPs to CD14+CD309+ cells ratio added to NT-proBNP, clinical data and cardiovascular risk factors has exhibited the best discriminate value and higher reliability to predict HFpEF compared with NTproBNP and clinical data/cardiovascular risk factors alone.
Subjects
CardiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 7 Dec 2015
Apoptotic-derived micro particles to endothelial-derived progenitor cells ratio as a novel biomarker in advanced heart failure patients
Editorial · 31 Oct 2020
Are Endothelial Cell-Derived Microparticles Predictive Biomarkers in Cardiovascular Diseases?
Editorial · 23 May 2016
Are Endothelial Cell-Derived Microparticles Predictive Biomarkers inCardiovascular Diseases?
Conference abstract · 29 Nov 2015
Circulating endothelial cell-derived micro-particles as a marker of clinical outcomes in chronic heart failure patients
More from this journal
The newest in Clinical and Experimental Cardiology.
Short communication · 4 Aug 2026
An effective determination method for aortic valve replacement through minimally invasive lower median sternotomy
Conference abstract · 15 Jun 2026
Speckle Tracking Echocardiography for Early Identification of Chemotherapy-Induced Cardiotoxicity
Conference abstract · 15 Jun 2026
Coronary CT Angiography as a First-Line Diagnostic Tool for Stable Chest Pain: Clinical Outcomes from a Multicenter Study
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical and Experimental Cardiology
- SubjectCardiology
- BylineArticles whose byline prints “Alexander E Berezin”

